KRYS
Price
$134.63
Change
-$4.80 (-3.44%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
3.89B
89 days until earnings call
UTHR
Price
$307.85
Change
-$2.95 (-0.95%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
13.9B
77 days until earnings call
Ad is loading...

KRYS vs UTHR

Header iconKRYS vs UTHR Comparison
Open Charts KRYS vs UTHRBanner chart's image
Krystal Biotech
Price$134.63
Change-$4.80 (-3.44%)
Volume$8.74K
Capitalization3.89B
United Therapeutics
Price$307.85
Change-$2.95 (-0.95%)
Volume$3.73K
Capitalization13.9B
KRYS vs UTHR Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. UTHR commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and UTHR is a Buy.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (KRYS: $139.43 vs. UTHR: $310.80)
Brand notoriety: KRYS and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 102% vs. UTHR: 79%
Market capitalization -- KRYS: $3.89B vs. UTHR: $13.9B
KRYS [@Biotechnology] is valued at $3.89B. UTHR’s [@Biotechnology] market capitalization is $13.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than KRYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while UTHR’s TA Score has 7 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 6 bearish.
  • UTHR’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than KRYS.

Price Growth

KRYS (@Biotechnology) experienced а -14.09% price change this week, while UTHR (@Biotechnology) price change was +4.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.49%. For the same industry, the average monthly price growth was +10.87%, and the average quarterly price growth was -7.60%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

UTHR is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+1.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.9B) has a higher market cap than KRYS($3.89B). KRYS has higher P/E ratio than UTHR: KRYS (32.26) vs UTHR (12.27). KRYS YTD gains are higher at: -10.998 vs. UTHR (-11.915). UTHR has higher annual earnings (EBITDA): 1.65B vs. KRYS (110M). UTHR has more cash in the bank: 3.27B vs. KRYS (598M). KRYS has less debt than UTHR: KRYS (7.26M) vs UTHR (300M). UTHR has higher revenues than KRYS: UTHR (2.88B) vs KRYS (291M).
KRYSUTHRKRYS / UTHR
Capitalization3.89B13.9B28%
EBITDA110M1.65B7%
Gain YTD-10.998-11.91592%
P/E Ratio32.2612.27263%
Revenue291M2.88B10%
Total Cash598M3.27B18%
Total Debt7.26M300M2%
FUNDAMENTALS RATINGS
KRYS vs UTHR: Fundamental Ratings
KRYS
UTHR
OUTLOOK RATING
1..100
5726
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
3524
SMR RATING
1..100
6747
PRICE GROWTH RATING
1..100
8659
P/E GROWTH RATING
1..100
9653
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UTHR's Valuation (67) in the Pharmaceuticals Other industry is in the same range as KRYS (72) in the Pharmaceuticals Major industry. This means that UTHR’s stock grew similarly to KRYS’s over the last 12 months.

UTHR's Profit vs Risk Rating (24) in the Pharmaceuticals Other industry is in the same range as KRYS (35) in the Pharmaceuticals Major industry. This means that UTHR’s stock grew similarly to KRYS’s over the last 12 months.

UTHR's SMR Rating (47) in the Pharmaceuticals Other industry is in the same range as KRYS (67) in the Pharmaceuticals Major industry. This means that UTHR’s stock grew similarly to KRYS’s over the last 12 months.

UTHR's Price Growth Rating (59) in the Pharmaceuticals Other industry is in the same range as KRYS (86) in the Pharmaceuticals Major industry. This means that UTHR’s stock grew similarly to KRYS’s over the last 12 months.

UTHR's P/E Growth Rating (53) in the Pharmaceuticals Other industry is somewhat better than the same rating for KRYS (96) in the Pharmaceuticals Major industry. This means that UTHR’s stock grew somewhat faster than KRYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSUTHR
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 6 days ago
69%
Declines
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 23 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 7 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Ad is loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA318.3820.12
+6.75%
Tesla
AAPL210.7912.52
+6.31%
Apple
SPY582.9918.65
+3.30%
SPDR® S&P 500® ETF
GME28.050.51
+1.85%
GameStop Corp
BTC.X102812.950000-1293.406200
-1.24%
Bitcoin cryptocurrency

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with IDYA. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+5.48%
IDYA - KRYS
55%
Loosely correlated
+5.34%
ACLX - KRYS
53%
Loosely correlated
+3.39%
CRNX - KRYS
53%
Loosely correlated
+8.60%
CGON - KRYS
52%
Loosely correlated
+5.98%
XNCR - KRYS
52%
Loosely correlated
+5.28%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
+3.11%
DAWN - UTHR
43%
Loosely correlated
+2.02%
GERN - UTHR
37%
Loosely correlated
+8.47%
KRYS - UTHR
36%
Loosely correlated
+5.48%
HALO - UTHR
34%
Loosely correlated
+1.08%
VKTX - UTHR
34%
Loosely correlated
+2.72%
More